390 related articles for article (PubMed ID: 11224987)
1. Chemoradiation in locally advanced non-small cell lung cancer.
Bonomi P; Shirazi W
Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
[No Abstract] [Full Text] [Related]
2. Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
Calvo AR; Belani CP
Cancer Treat Res; 2001; 105():189-227. PubMed ID: 11224988
[No Abstract] [Full Text] [Related]
3. [Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].
Souquet PJ; Gerinière L
Bull Cancer; 2002 Aug; 89 Spec No():S80-4. PubMed ID: 12449035
[TBL] [Abstract][Full Text] [Related]
4. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
Mavroudis D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
[No Abstract] [Full Text] [Related]
5. Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
Tumolo S; Toffoli G; Saracchini S; Lo Re G; Bruschi G; Boccieri MG
Lung Cancer; 2001 Dec; 34 Suppl 4():S37-46. PubMed ID: 11742701
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
[TBL] [Abstract][Full Text] [Related]
7. [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].
Morere JF
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S37-41. PubMed ID: 11924242
[No Abstract] [Full Text] [Related]
8. [Gemcitabine].
Takeda K
Nihon Rinsho; 2002 May; 60 Suppl 5():359-65. PubMed ID: 12101689
[No Abstract] [Full Text] [Related]
9. Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
Rigas JR
Semin Oncol; 2001 Jun; 28(3 Suppl 9):15-20. PubMed ID: 11441410
[TBL] [Abstract][Full Text] [Related]
10. [Developed new agents for lung cancer].
Kato Y; Saijo N
Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):218-23. PubMed ID: 11904983
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in metastatic non-small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):15-27. PubMed ID: 10981287
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer. Thoracic Oncology Program.
Ornstein DL; Nervi AM; Rigas JR
Ann Oncol; 1999; 10 Suppl 5():S35-40. PubMed ID: 10582137
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy for elderly patients with lung cancer].
Okamoto H; Watanabe K
Nihon Rinsho; 2002 May; 60 Suppl 5():591-5. PubMed ID: 12101743
[No Abstract] [Full Text] [Related]
14. [Chemotherapy for advanced non-small cell lung cancer].
Ueoka H
Gan To Kagaku Ryoho; 2005 Jun; 32(6):770-6. PubMed ID: 15984514
[TBL] [Abstract][Full Text] [Related]
15. [Outpatient chemotherapy for lung cancer].
Yoneda S
Gan To Kagaku Ryoho; 2007 Apr; 34(4):533-7. PubMed ID: 17431337
[TBL] [Abstract][Full Text] [Related]
16. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
17. Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.
Simon GR; Bunn PA
Cancer Invest; 2003; 21(1):87-104. PubMed ID: 12643013
[TBL] [Abstract][Full Text] [Related]
18. [Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?].
Pujol JL; Choma D; Jacot W; Quantin X
Bull Cancer; 2002 Aug; 89 Spec No():S85-90. PubMed ID: 12449036
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data.
Santana-Davila R; Szabo A; Arce-Lara C; Williams CD; Kelley MJ; Whittle J
J Thorac Oncol; 2014 May; 9(5):702-9. PubMed ID: 24662458
[TBL] [Abstract][Full Text] [Related]
20. Perspectives and opportunities: Docetaxel in the current and future treatment of non-small cell lung cancer.
Green MR
Semin Oncol; 2002 Jun; 29(3 Suppl 12):17-21. PubMed ID: 12170447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]